Yuyu Pharma Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,673
11,585
11,669
10,333
20,312
27,512
Total Accounts Receivable
21,849
24,914
25,352
25,250
21,597
22,431
Inventories
8,126
7,098
8,224
12,789
19,593
15,616
Other Current Assets
721
309
329
643
1,967
3,310
Total Current Assets
33,369
43,906
45,574
49,016
63,470
68,870
Net Property, Plant & Equipment
45,768
44,845
46,519
47,226
49,722
57,812
Total Investments and Advances
4,410
3,521
6,242
5,188
4,201
4,426
Long-Term Note Receivable
-
-
-
-
455
2,417
Intangible Assets
2,152
2,209
2,136
2,223
1,873
1,703
Other Assets
1,768
1,500
-
-
1,602
-
Total Assets
88,680
96,265
101,401
104,327
124,554
139,314
ST Debt & Current Portion LT Debt
900
3,897
5,030
17,444
18,070
Accounts Payable
4,938
4,355
3,224
4,880
8,453
Income Tax Payable
1,448
670
1,027
972
150
Other Current Liabilities
5,883
6,640
13,620
5,911
8,810
Total Current Liabilities
13,168
15,562
22,901
29,207
35,484
Long-Term Debt
200
3,956
-
-
1,349
Provision for Risks & Charges
5,167
4,364
6,915
1,207
1,565
Deferred Taxes
1,213
284
930
674
168
Other Liabilities
643
106
95
183
259
Total Liabilities
19,179
23,988
29,912
30,597
41,720
Common Equity (Total)
69,421
71,373
70,419
72,859
81,963
Total Shareholders' Equity
69,421
71,373
70,419
72,859
81,963
Total Equity
69,501
72,276
71,489
73,731
82,834
Liabilities & Shareholders' Equity
88,680
96,265
101,401
104,327
124,554
Accumulated Minority Interest
81
904
1,070
872
871

About Yuyu Pharma

View Profile
Address
94 Bio valley 1-ro
Jecheon NC 27159
Korea, Republic Of
Employees -
Website http://www.yuyu.co.kr
Updated 07/08/2019
Yuyu Pharma, Inc. engages in the manufacture and sale of pharmaceuticals. It operates through the Prescription and Non-prescription divisions. The Prescription division provides circulatory improvement agents, bone metabolism ameliorants, antihypertensive drugs, topical corticosteroids, antiplatelet agents, gout prepartions, angina pectoris drugs, osteoporosis drugs, antidiabetic agents, antibiotics, antiulcerants, varicose preparations, antitubercular agents, and hemorrhoidal.